WRLD A.LIVE

23:001 report

• Novo’s Answer to Retatrutide Does Well at Phase II in Type 2 Diabetes Inside Precision Medicine

22:00nothing heard

21:001 report

• Longer Sleep Duration Linked to Progression of Diabetic Nephropathy Neurology Advisor

20:001 report

• Sleep Duration Tied to Diabetic Kidney and Nerve Complications, but Not DR Review of Optometry

19:001 report

• Age no bar- SGLT2 Inhibitors May Offer Benefits in CKD Patients Aged 80 and Older: Study Medical Dialogues

18:001 report

• Magnesium Status and Its Association With Glycemic Control and Diabetes-Related Complications in Type 2 Diabetes Mellitus: A Systematic Review Cureus

17:00nothing heard

16:00nothing heard

15:00nothing heard

14:00nothing heard

13:001 report

• Geriatric chronic kidney disease patients benefit from SGLT2 inhibition News-Medical

12:00nothing heard

11:00nothing heard

10:001 report

• Navigating the Glucose Surge: Painful Trigeminal Neuropathy and Transient Speech Disturbance in a Patient With Severe Hyperglycemia and Rapid Glycemic Correction Cureus

09:00nothing heard

08:00nothing heard

07:00nothing heard

06:00nothing heard

05:001 report

• Human dignity and its associations with self efficacy and treatment adherence in adults with type 2 diabetes in Iran Nature

04:00nothing heard

03:00nothing heard

02:00nothing heard

01:00nothing heard

00:003 reports

• Advanced Age Does Not Limit the Benefits of Sodium-Glucose Cotransporter 2 Inhibitors in Chronic Kidney Disease | Newswise Newswise
• The Role and Mechanism of SGLT2 Inhibitors in Chronic Kidney Disease Dove Medical Press
• SGLT2 Inhibitors Benefit Frail Adults With T2D, Remain Underused Pharmacy Times